Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OCD Indication Approved For Brainsway TMS Device

Aug 17 2018

• By Sue Darcey

Related Content

First FDA clearance for TMS in depression; could be effective in coma

Oct 28 2008

Nexstim Looks To Break Into US TMS Market With Depression Indication

Jul 12 2017

Additional Topics

United States Approvals Regulation Medical Device

More from Approvals

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window